TCI Wealth Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

TCI Wealth Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27	Closed	-$1K	–	1487
2017 Q4	$1K	Hold	27	–	–	﹤0.01%	1352
2017 Q3	$1K	Hold	27	–	–	﹤0.01%	1294
2017 Q2	$1K	Buy	+27	New	+$666	﹤0.01%	1305
2017 Q1	–	Sell	-20	Closed	–	–	1441
2016 Q4	$0	Hold	20	–	–	﹤0.01%	1508
2016 Q3	$1K	Buy	+20	New	+$622	﹤0.01%	1315

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

TCI Wealth Advisors's JUNO Position: Q1 2018 in Review

TCI Wealth Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 27 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in JUNO in Q3 2016 and held it in 5 quarters. The position peaked at $1K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

TCI Wealth Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
TCI Wealth Advisors sold 27 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1K.
TCI Wealth Advisors first reported a position in Juno Therapeutics, Inc. in Q3 2016 and held it in 5 quarters.
TCI Wealth Advisors's Juno Therapeutics, Inc. position peaked at $1K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on TCI Wealth Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.